Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sensitivity, specificity, and vaccine efficacy

P A Lachenbruch1

  • 1U.S. Food and Drug Administration, Center for Biologics Evaluation and Research, Rockville, Maryland 20852, USA.

Controlled Clinical Trials
|January 6, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Observations on the relationship between frequency and timing of intercourse and the probability of conception.

Population studies·2011
Same author

Frequency and timing of intercourse: Its relation to the probability of conception.

Population studies·2011
Same author

The Cutaneous Assessment Tool: development and reliability in juvenile idiopathic inflammatory myopathy.

Rheumatology (Oxford, England)·2007
Same author

Lot consistency as an equivalence problem.

Journal of biopharmaceutical statistics·2004
Same author

Repeated measures with zeros.

Statistical methods in medical research·2002
Same author

Analysis of studies to evaluate immune response to combination vaccines.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2001
Same journal

On the generation and ownership of alpha in medical studies.

Controlled clinical trials·2004
Same journal

An analysis of the effect of funding source in randomized clinical trials of second generation antipsychotics for the treatment of schizophrenia.

Controlled clinical trials·2004
Same journal

Symptom recording in a randomised clinical trial: paper diaries vs. electronic or telephone data capture.

Controlled clinical trials·2004
Same journal

Statistical comparison of random allocation methods in cancer clinical trials.

Controlled clinical trials·2004
Same journal

Analyzing bronchodilation with emphasis on disease type, age and sex.

Controlled clinical trials·2004
Same journal

Geographic variability in patient characteristics, treatment and outcome in an International Trial of Magnesium in acute myocardial infarction.

Controlled clinical trials·2004
See all related articles

Imperfect test specificity can lower vaccine efficacy (VE) estimates. Adjusting for test accuracy increases variance and sample size needs, while using the diagnostic method as the disease definition is an alternative approach.

Area of Science:

  • Epidemiology
  • Biostatistics
  • Vaccinology

Background:

  • Accurate estimation of vaccine efficacy (VE) is crucial for public health.
  • Diagnostic tests used in VE studies may have imperfect sensitivity and specificity.
  • Imperfect test characteristics can introduce bias into VE estimates.

Purpose of the Study:

  • To evaluate the impact of imperfect test sensitivity and specificity on vaccine efficacy estimation.
  • To explore methods for adjusting VE estimates in the presence of diagnostic test inaccuracies.
  • To assess the trade-offs between adjustment methods and alternative diagnostic approaches.

Main Methods:

  • Mathematical modeling to assess the effects of imperfect test characteristics on VE.
  • Simulation studies to quantify bias and variance under different scenarios.

Related Experiment Videos

  • Comparison of VE estimation with and without adjustments for sensitivity and specificity.

    • Main Results:

    • Reduced test specificity (i.e., misclassifying non-cases as cases) leads to an underestimation of VE.
    • Adjusting VE estimates for known sensitivity and specificity increases the variance of the estimate.
    • Increased variance necessitates larger sample sizes for achieving desired statistical power.

    Conclusions:

    • Imperfect diagnostic test accuracy, particularly low specificity, can significantly bias VE estimates.
    • Methods to adjust for test inaccuracies increase statistical uncertainty and sample size requirements.
    • Adopting the diagnostic method as the definitive disease definition presents an alternative strategy to manage bias and uncertainty in VE studies.